Dementia
Rules must evolve to allow new drugs for early Alzheimer's
(HealthDay)—Given the shift in the focus of drug development for Alzheimer's disease toward earlier disease stages, before the onset of dementia, regulatory guidelines need to evolve, according to a perspective ...
Alzheimer's disease & dementia
Mar 14, 2013 |
4 / 5 (2) |
0
Mutations in VCP gene implicated in a number of neurodegenerative diseases
New research, published in Neuron, gives insight into how single mutations in the VCP gene cause a range of neurological conditions including a form of dementia called Inclusion Body Myopathy, Paget's Disease of the Bone a ...
Neuroscience
Mar 14, 2013 |
not rated yet |
0
Rapid hearing loss may be a symptom of rare Creutzfeldt-Jakob Disease
Rapid hearing loss in both ears may be a symptom of the rare but always-fatal Creutzfeldt-Jakob Disease and should be considered a reason for clinicians to test for the disorder.
Neuroscience
Mar 14, 2013 |
not rated yet |
0
Dwelling on stressful events can increase inflammation in the body, study finds
Dwelling on negative events can increase levels of inflammation in the body, a new Ohio University study finds. Researchers discovered that when study participants were asked to ruminate on a stressful incident, their levels ...
Psychology & Psychiatry
Mar 13, 2013 |
5 / 5 (1) |
0
New app for dementia assessment
A team of clinicians from Sydney, Australia and Plymouth, UK, have taken the paper-based Addenbrooke's Cognitive Examination (ACE-III), one of the most popular and commonly-used screening tools for dementia and translated ...
Alzheimer's disease & dementia
Mar 12, 2013 |
not rated yet |
0
Stroke risk in elderly treated with antipsychotics is newly linked to specific drug actions
Antipsychotic administration in the elderly is associated with an increased risk for cerebrovascular accident, more commonly known as stroke; a new study published in Biological Psychiatry provides additional insight into t ...
Psychology & Psychiatry
Mar 11, 2013 |
not rated yet |
0
Aerobic exercise promotes post-concussion healing, researchers find
(Medical Xpress)—Further evidence that a program of controlled, progressive aerobic exercise may help restore normal cognitive function in patients who have sustained a concussion has been published by ...
Neuroscience
Mar 07, 2013 |
not rated yet |
0
Short bouts of exercise boost self control
Short bouts of moderately intense exercise seem to boost self control, indicates an analysis of the published evidence in the British Journal of Sports Medicine.
Health
Mar 06, 2013 |
4 / 5 (1) |
0
New research shows anti-wrinkle cream chemical works
(Medical Xpress)—University of Reading researchers have found that a chemical used in some anti-wrinkle creams can nearly double the amount of the protein collagen needed to give skin its elasticity.
Medications
Mar 06, 2013 |
4 / 5 (1) |
1
Age-related dementia may begin with neurons' inability to dispose of unwanted proteins
A team of European scientists from the University Medical Center Hamburg-Eppendorf (UKE) and the Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD) at the University of Cologne in ...
Alzheimer's disease & dementia
Mar 05, 2013 |
5 / 5 (1) |
0
Could a common blood pressure drug slow down the progression of Alzheimer's?
A ground-breaking trial that hopes to discover if a drug commonly used to treat high blood pressure could slow down the progression of Alzheimer's disease (AD) will begin shortly.
Alzheimer's disease & dementia
Mar 04, 2013 |
3.8 / 5 (4) |
0
Clogged heart arteries can foreshadow stroke
Blockages in your heart arteries could mean you're more likely to have a stroke, even if you're considered low risk, according to research in the American Heart Association journal Stroke.
Cardiology
Feb 28, 2013 |
5 / 5 (1) |
0
Foundation releases second list of medical 'don'ts' for America's doctors
Doctors should avoid 90 medical procedures that are performed regularly but often cost too much or do little good, according to a new list of expert recommendations.
Health
Feb 25, 2013 |
5 / 5 (1) |
0
Antioxidants in your diet may not reduce risk of stroke or dementia
Contrary to other research, a new study found that the total level of antioxidants in people's diets is not related to their risk of developing stroke or dementia. The study is published in the February 20, 2013, online issue ...
Neuroscience
Feb 20, 2013 |
not rated yet |
0
Paving the way for better sleep in Alzheimer's
A new sleep pattern monitoring system has been developed by UK researchers to help spot sleep disturbance in people diagnosed with early dementia. The system, known as PAViS, could be used remotely by healthcare workers to ...
Alzheimer's disease & dementia
Feb 19, 2013 |
not rated yet |
0
Dementia (taken from Latin, originally meaning "madness", from de- "without" + ment, the root of mens "mind") is a serious loss of global cognitive ability in a previously unimpaired person, beyond what might be expected from normal aging. It may be static, the result of a unique global brain injury, or progressive, resulting in long-term decline due to damage or disease in the body. Although dementia is far more common in the geriatric population, it can occur before the age of 65, in which case it is termed "early onset dementia".
Dementia is not a single disease, but rather a non-specific illness syndrome (i.e., set of signs and symptoms) in which affected areas of cognition may be memory, attention, language, and problem solving. It is normally required to be present for at least 6 months to be diagnosed; cognitive dysfunction that has been seen only over shorter times, in particular less than weeks, must be termed delirium. In all types of general cognitive dysfunction, higher mental functions are affected first in the process.
Especially in the later stages of the condition, affected persons may be disoriented in time (not knowing what day of the week, day of the month, or even what year it is), in place (not knowing where they are), and in person (not knowing who they, or others around them, are). Dementia, though often treatable to some degree, is usually due to causes that are progressive and incurable.
Symptoms of dementia can be classified as either reversible or irreversible, depending upon the etiology of the disease. Less than 10% of cases of dementia are due to causes that may presently be reversed with treatment. Causes include many different specific disease processes, in the same way that symptoms of organ dysfunction such as shortness of breath, jaundice, or pain are attributable to many etiologies.
Without careful assessment of history, the short-term syndrome of delirium (often lasting days to weeks) can easily be confused with dementia, because they have all symptoms in common, save duration. Some mental illnesses, including depression and psychosis, may produce symptoms that must be differentiated from both delirium and dementia.
There are many specific types (causes) of dementia, often showing slightly different symptoms. However, the symptom overlap is such that it is impossible to diagnose the type of dementia by symptomatology alone, and in only a few cases are symptoms enough to give a high probability of some specific cause. Diagnosis is therefore aided by nuclear medicine brain scanning techniques. Certainty cannot be attained except with brain biopsy during life, or at necropsy in death.
Some of the most common forms of dementia are: Alzheimer's disease, vascular dementia, frontotemporal dementia, semantic dementia and dementia with Lewy bodies. It is possible for a patient to exhibit two or more dementing processes at the same time, as none of the known types of dementia protects against the others.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Latest Spotlight News
Researchers suggest boosting body's natural flu killers
A known difficulty in fighting influenza (flu) is the ability of the flu viruses to mutate and thus evade various medications that were previously found to be effective. Researchers at the Hebrew University of Jerusalem have ...
Pay attention: How we focus and concentrate
Scientists at Newcastle University have shed new light on how the brain tunes in to relevant information.
New discovery in fight against deadly meningococcal disease
Professor Michael Jennings, Deputy Director of the Institute for Glycomics at Griffith University, was part of an international team that discovered the previously unknown pathway of how the bacterium colonizes people.
Are kids who take music lessons different from other kids?
(Medical Xpress)—Research by U of T Mississauga psychology professor Glenn Schellenberg reveals that two key personality traits – openness-to-experience and conscientiousness—predict better than IQ ...
Study reveals active site of enzyme linked to stuttering
(Medical Xpress)—Scientists from the Joint Center for Structural Genomics (JCSG) at SLAC National Accelerator Laboratory have determined the 3-D structure of the chemically active part of an enzyme involved ...
Cold plasma successful against brain cancer cells
For the first time, physicists from the Max Planck Institute for Extraterrestrial Physics (MPE), biologists and physicians demonstrated the synergistic effect of cold atmospheric plasma - a partly ionized ...
Can you put a price on health?
As health services strive to improve quality and reduce costs, researchers study the benefits – and the pitfalls – of 'pay for performance' in hospitals.
Vaccine blackjack: IL-21 critical to fight against viral infections
(Medical Xpress)—Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.
Depression linked to telomere enzyme, aging, chronic disease
(Medical Xpress)—The first symptoms of major depression may be behavioral, but the common mental illness is based in biology—and not limited to the brain.
Researchers find possible 'master switch' in deadly brain cancer
(Medical Xpress)—Researchers at the University of Virginia School of Medicine have identified a promising target for treating glioblastoma, one that appears to avoid many of the obstacles that typically frustrate efforts ...